osteoporosis Archives -

UCB/Amgen’s Evenity approved in Europe after appeal

https://pharmaphorum.com/news/ucb-amgens-evenity-approved-in-europe-after-appeal/

Patient voice overcomes EU ‘no’ for UCB/Amgen’s osteoporosis drug

https://pharmaphorum.com/news/ucb-overcomes-eu-no-for-osteoporosis-drug-with-patient-testimony/

Vitamin K Market will reach over $1,000 million by 2025

https://pharmaphorum.com/partner-content/vitamin-k-market-will-reach-over-1000-million-by-2025/

https://pharmaphorum.com/news/lilly-faces-biosimilar-rivals-to-osteoporosis-drug-forsteo-in-europe/

CHMP says no to Amgen’s osteoporosis drug Evenity

https://pharmaphorum.com/news/chmp-says-no-to-amgens-osteoporosis-drug-evenity/

At long last, Amgen/UCB score FDA okay for Evenity

https://pharmaphorum.com/news/at-long-last-amgen-ucb-score-fda-okay-for-evenity/

FDA advisers back Amgen/UCB’s osteoporosis drug Evenity

https://pharmaphorum.com/news/fda-advisers-back-amgen-ucbs-osteoporosis-drug-evenity/

Japan approves Amgen’s osteoporosis drug

https://pharmaphorum.com/news/japan-approves-amgens-osteoporosis-drug/

Amgen and UCB re-file Evenity for US approval

https://pharmaphorum.com/news/amgen-ucb-evenity-fda-filing/

Search